Rici Healthcare Reports 7% Decline in Revenue for H1 2025, Net Profit Down Compared to H1 2024

Reuters
Aug 28
Rici Healthcare Reports 7% Decline in Revenue for H1 2025, Net Profit Down Compared to H1 2024

Rici Healthcare Holdings Ltd. has announced its unaudited consolidated financial results for the six months ended June 30, 2025. The company's revenue for this period was RMB1,144.8 million, marking a 7.0% decrease from the RMB1,231.2 million reported for the same period in 2024. The total comprehensive income for the period was RMB78.7 million, compared to RMB87.7 million in the previous year. The segment profit for the General Hospital and Medical Examination divisions was RMB33.3 million and RMB241.5 million, respectively. Administrative expenses amounted to RMB116.7 million. The company's gross profit for the six months ended June 30, 2025, was RMB407.6 million. Rici Healthcare continues its principal engagement in providing general hospital examination services, with operations in the Cayman Islands. The results reflect the company's performance and strategic positioning within the healthcare sector.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Rici Healthcare Holdings Ltd. published the original content used to generate this news brief on August 28, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10